167 related articles for article (PubMed ID: 38396242)
1. An M cell-targeting recombinant L. lactis vaccine against four H. pylori adhesins.
Zhang F; Shi T; Zhang Z; Wang S; Liu J; Li Y; Wang X; Liu K; Guo L
Appl Microbiol Biotechnol; 2024 Feb; 108(1):231. PubMed ID: 38396242
[TBL] [Abstract][Full Text] [Related]
2. Oral Immunization With a M Cell-Targeting Recombinant
Guo L; Zhang F; Wang S; Li R; Zhang L; Zhang Z; Yin R; Liu H; Liu K
Front Immunol; 2022; 13():918160. PubMed ID: 35911756
[TBL] [Abstract][Full Text] [Related]
3. Recombinant L. lactis vaccine LL-plSAM-WAE targeting four virulence factors provides mucosal immunity against H. pylori infection.
Zhang F; Ni L; Zhang Z; Luo X; Wang X; Zhou W; Chen J; Liu J; Qu Y; Liu K; Guo L
Microb Cell Fact; 2024 Feb; 23(1):61. PubMed ID: 38402145
[TBL] [Abstract][Full Text] [Related]
4. Immunologic properties and therapeutic efficacy of a multivalent epitope-based vaccine against four Helicobacter pylori adhesins (urease, Lpp20, HpaA, and CagL) in Mongolian gerbils.
Guo L; Yin R; Xu G; Gong X; Chang Z; Hong D; Liu H; Ding S; Han X; Li Y; Tang F; Liu K
Helicobacter; 2017 Dec; 22(6):. PubMed ID: 28851031
[TBL] [Abstract][Full Text] [Related]
5. Delivery of Helicobacter pylori HpaA to gastrointestinal mucosal immune sites using Lactococcus lactis and its immune efficacy in mice.
Zhang R; Wang C; Cheng W; Duan G; Shi Q; Chen S; Fan Q
Biotechnol Lett; 2018 Mar; 40(3):585-590. PubMed ID: 29299716
[TBL] [Abstract][Full Text] [Related]
6. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
Li X; Xing Y; Guo L; Lv X; Song H; Xi T
Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988
[TBL] [Abstract][Full Text] [Related]
7. Construction of a recombinant Lactococcus lactis strain expressing a fusion protein of Omp22 and HpaA from Helicobacter pylori for oral vaccine development.
Zhang R; Duan G; Shi Q; Chen S; Fan Q; Sun N; Xi Y
Biotechnol Lett; 2016 Nov; 38(11):1911-1916. PubMed ID: 27406731
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of oral vaccination with Lactococcus lactis derived vaccine candidate antigen (UreB) of Helicobacter pylori fused with the human interleukin 2 as adjuvant.
Zhang HX; Qiu YY; Zhao YH; Liu XT; Liu M; Yu AL
Mol Cell Probes; 2014 Feb; 28(1):25-30. PubMed ID: 24036137
[TBL] [Abstract][Full Text] [Related]
9. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy of oral immunization with a non-genetically modified Lactococcus lactis-based vaccine CUE-GEM induces local immunity against Helicobacter pylori infection.
Liu W; Tan Z; Xue J; Luo W; Song H; Lv X; Zheng T; Xi T; Xing Y
Appl Microbiol Biotechnol; 2016 Jul; 100(14):6219-6229. PubMed ID: 26846746
[TBL] [Abstract][Full Text] [Related]
11. Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice.
Lee MH; Roussel Y; Wilks M; Tabaqchali S
Vaccine; 2001 Jul; 19(28-29):3927-35. PubMed ID: 11427267
[TBL] [Abstract][Full Text] [Related]
12. A food-grade engineered Lactococcus lactis strain delivering Helicobacter pylori Lpp20 alleviates bacterial infection in H. pylori-challenged mice.
Sun N; Zhang R; Duan G; Peng X; Wang C; Chen S; Fan Q
Biotechnol Lett; 2019 Dec; 41(12):1415-1421. PubMed ID: 31620902
[TBL] [Abstract][Full Text] [Related]
13. Protection against Helicobacter pylori infection by a trivalent fusion vaccine based on a fragment of urease B-UreB414.
Wang L; Liu XF; Yun S; Yuan XP; Mao XH; Wu C; Zhang WJ; Liu KY; Guo G; Lu DS; Tong WD; Wen AD; Zou QM
J Microbiol; 2010 Apr; 48(2):223-8. PubMed ID: 20437155
[TBL] [Abstract][Full Text] [Related]
14. An engineered Lactococcus lactis strain exerts significant immune responses through efficient expression and delivery of Helicobacter pylori Lpp20 antigen.
Zhang R; Peng X; Duan G; Shi Q; Chen S; Wang C; Fan Q; Xi Y
Biotechnol Lett; 2016 Dec; 38(12):2169-2175. PubMed ID: 27646988
[TBL] [Abstract][Full Text] [Related]
15. Surface expression of Helicobacter pylori HpaA adhesion antigen on Vibrio cholerae, enhanced by co-expressed enterotoxigenic Escherichia coli fimbrial antigens.
Tobias J; Lebens M; Wai SN; Holmgren J; Svennerholm AM
Microb Pathog; 2017 Apr; 105():177-184. PubMed ID: 28215587
[TBL] [Abstract][Full Text] [Related]
16. A truncated form of HpaA is a promising antigen for use in a vaccine against Helicobacter pylori.
Flach CF; Svensson N; Blomquist M; Ekman A; Raghavan S; Holmgren J
Vaccine; 2011 Feb; 29(6):1235-41. PubMed ID: 21147129
[TBL] [Abstract][Full Text] [Related]
17. Nongenetically modified Lactococcus lactis-adjuvanted vaccination enhanced innate immunity against Helicobacter pylori.
Liu W; Tan Z; Liu H; Zeng Z; Luo S; Yang H; Zheng L; Xi T; Xing Y
Helicobacter; 2017 Oct; 22(5):. PubMed ID: 28805287
[TBL] [Abstract][Full Text] [Related]
18. Oral vaccination of mice against Helicobacter pylori with recombinant Lactococcus lactis expressing urease subunit B.
Gu Q; Song D; Zhu M
FEMS Immunol Med Microbiol; 2009 Aug; 56(3):197-203. PubMed ID: 19453750
[TBL] [Abstract][Full Text] [Related]
19. Protection Against
Pan X; Ke H; Niu X; Li S; Lv J; Pan L
Front Immunol; 2018; 9():1003. PubMed ID: 29867978
[TBL] [Abstract][Full Text] [Related]
20. [Expression of helicobacter pylori alpA gene in lactococcus lactis and its immunogenicity analysis].
Sun ZL; Bi YW; Bai CM; Gao DD; Li ZH; Dai ZX; Li JF; Xu WM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Mar; 26(3):203-6. PubMed ID: 20230679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
